P140Cap suppresses the invasive properties of highly metastatic MTLn3-EGFR cells via impaired cortactin phosphorylation

Oncogene

Volumn 31, Issue 5, 2012, Pages 624-633

  Damiano, L ^a   Le Devedec S E ^b   Di Stefano, P ^a   Repetto, D ^a   Lalai, R ^b   Truong, H ^b   Xiong, J L ^b   Danen, E H ^b   Yan, K ^c   Verbeek, F J ^c   De Luca, E ^a   Attanasio, F ^d   Buccione, R ^d   Turco, E ^a   Van De Water, B ^b   Defilippi, P ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b LEIDEN UNIVERSITY   (Netherlands)

^c LEIDEN UNIVERSITY   (Netherlands)

^d NONE   (Italy)

Author keywords

breast cancer; cortactin; metastasis; p140Cap; tumor invasion

Indexed keywords

ADAPTOR PROTEIN; CORTACTIN; PROTEIN P140CAP; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CELL INVASION; CELL MOTILITY; CONTROLLED STUDY; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ADENOCARCINOMA; ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CORTACTIN; EPIDERMAL GROWTH FACTOR; GREEN FLUORESCENT PROTEINS; HEK293 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, KNOCKOUT; MICROSCOPY, FLUORESCENCE, MULTIPHOTON; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; PHOSPHORYLATION; PROTEIN BINDING; RATS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA INTERFERENCE; TRANSPLANTATION, HETEROLOGOUS;

MUS; RATTUS;

EID: 84856550289     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.257     Document Type: Article

References (35)

1. Ayala I, BaldassarreM, Giacchetti G, Caldieri G, Tete S, Luini A et al. (2008). Multiple regulatory inputs converge on cortactin to control invadopodia biogenesis and extracellular matrix degradation. J Cell Sci 121: 369-378. (Pubitemid 351356708)
2. Baldassarre M, Ayala I, Beznoussenko G, Giacchetti G, Machesky LM, Luini A et al. (2006). Actin dynamics at sites of extracellular matrix degradation. Eur J Cell Biol 85: 1217-1231. (Pubitemid 44780616)
3. Bowden ET, Coopman PJ, Mueller SC. (2001). Invadopodia: unique methods for measurement of extracellular matrix degradation in vitro. Methods Cell Biol 63: 613-627.
4. Buccione R, Caldieri G, Ayala I. (2009). Invadopodia: specialized tumour cell structures for the focal degradation of the extracellular matrix. Cancer Metastasis Rev 28: 137-149.
5. Cabodi S, Camacho Leal MP, Di Stefano P, Defilippi P. (2010). Integrin signalling adaptors: not only figurants in the cancer story. Nat Rev Cancer 2010: 858-870.
6. Chin LS, Nugent RD, Raynor MC, Vavalle JP, Li L. (2000). SNIP, a novel SNAP-25-interacting protein implicated in regulated exocytosis. J Biol Chem 275: 1191-1200. (Pubitemid 30051171)
7. Citri A, Yarden Y. (2006). EGF-ERBB signalling: towards the systems level. Nat Rev Mol Cell Biol 7: 505-516. (Pubitemid 44036456)
8. Condeelis J, Segall JE. (2003). Intravital imaging of cell movement in tumours. Nat Rev Cancer 3: 921-930. (Pubitemid 37500177)
9. Damiano L, Di Stefano P, Camacho Leal MP, Barba M, Mainiero F, Cabodi S et al. (2010). p140Cap dual regulation of E-cadherin/EGFR cross-talk and Ras signalling in tumour cell scatter and proliferation. Oncogene 29: 3677-3690.
10. Di Stefano P, Cabodi S, Boeri Erba E, Margaria V, Bergatto E, Giuffrida MG et al. (2004). P130Cas-associated protein (p140Cap) as a new tyrosine-phosphorylated protein involved in cell spreading. Mol Biol Cell 15: 787-800. (Pubitemid 38146493)
11. Di Stefano P, Damiano L, Cabodi S, Aramu S, Tordella L, Praduroux A et al. (2007). p140Cap protein suppresses tumour cell properties, regulating Csk and Src kinase activity. EMBO J 26: 2843-2855. (Pubitemid 46975776)
12. Gardel ML, Schneider IC, Aratyn-Schaus Y, Waterman CM. (2010). Mechanical integration of actin and adhesion dynamics in cell migration. Annu Rev Cell Dev Biol 26: 315-333.
13. Head JA, Jiang D, Li M, Zorn LJ, Schaefer EM, Parsons JT et al. (2003). Cortactin tyrosine phosphorylation requires Rac1 activity and association with the cortical actin cytoskeleton. Mol Biol Cell 14: 3216-3229. (Pubitemid 37013122)
14. Ilic D, Furuta Y, Kanazawa S, Takeda N, Sobue K, Nakatsuji N et al. (1995). Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 377: 539-544.
15. Jaworski J, Kapitein LC, Gouveia SM, Dortland BR, Wulf PS, Grigoriev I et al. (2009). Dynamic microtubules regulate dendritic spine morphology and synaptic plasticity. Neuron 61: 85-100.
16. Le Devedec SE, van Roosmalen W, Maria N, Grimbergen M, Pont C, Lalai R et al. (2009). An improved model to study tumour cell autonomous metastasis programs using MTLn3 cells and the Rag2(-/-) gammac (-/-) mouse. Clin Exp Metastasis 26: 673-684.
17. Li Y, Tondravi M, Liu J, Smith E, Haudenschild CC, Kaczmarek M et al. (2001). Cortactin potentiates bone metastasis of breast cancer cells. Cancer Res 61: 6906-6911. (Pubitemid 32896517)
18. Lim ST, Mikolon D, Stupack DG, Schlaepfer DD. (2008). FERM control of FAK function: implications for cancer therapy. Cell Cycle 7: 2306-2314.
19. Lorenz M, DesMarais V, Macaluso F, Singer RH, Condeelis J. (2004). Measurement of barbed ends, actin polymerization, and motility in live carcinoma cells after growth factor stimulation. Cell Motil Cytoskeleton 57: 207-217. (Pubitemid 38419153)
20. Lua BL, Low BC. (2005). Cortactin phosphorylation as a switch for actin cytoskeletal network and cell dynamics control. FEBS Lett 579: 577-585.
21. Mader CC, Oser M, Magalhaes MA, Bravo-Cordero JJ, Condeelis J, Koleske AJ, Gil-Henn H. (2011). An EGFR-Src-Arg-cortactin pathway mediates functional maturation of invadopodia and breast cancer cell invasion. Cancer Res 71: 1730-1741.
22. Marxfeld H, Staedtler F, Harleman JH. (2006). Characterisation of two rat mammary tumour models for breast cancer research by gene expression profiling. Exp Toxicol Pathol 58: 133-143. (Pubitemid 44635150)
23. Mori S, Chang JT, Andrechek ER, Matsumura N, Baba T, Yao G et al. (2009). Anchorage-independent cell growth signature identifies tumours with metastatic potential. Oncogene 28: 2796-2805.
24. Neri A, Nicolson GL. (1981). Phenotypic drift of metastatic and cellsurface properties of mammary adenocarcinoma cell clones during growth in vitro. Int J Cancer 28: 731-738. (Pubitemid 12245898)
25. Normanno N, De Luca A, Bianco C, Strizzi L, Mancino M, Maiello MR et al. (2006). Epidermal growth factor receptor (EGFR) signalling in cancer. Gene 366: 2-16. (Pubitemid 43199589)
26. Oser M, Yamaguchi H, Mader CC, Bravo-Cordero JJ, Arias M, Chen X et al. (2009). Cortactin regulates cofilin and N-WASp activities to control the stages of invadopodium assembly and maturation. J Cell Biol 186: 571-587.
27. Sahai E. (2007). Illuminating the metastatic process. Nat Rev Cancer 7: 737-749. (Pubitemid 47463672)
28. Vicente-Manzanares M, Webb DJ, Horwitz AR. (2005). Cell migration at a glance. J Cell Sci 118: 4917-4919. (Pubitemid 41672422)
29. Weaver AM. (2008). Cortactin in tumour invasiveness. Cancer Lett 265: 157-166.
30. Webb DJ, Zhang H, Horwitz AF. (2005). Cell migration: an overview. Methods Mol Biol 294: 3-11.
31. Weed SA, Karginov AV, Schafer DA, Weaver AM, Kinley AW, Cooper JA et al. (2000). Cortactin localization to sites of actin assembly in lamellipodia requires interactions with F-actin and the Arp2/3 complex. J Cell Biol 151: 29-40.
32. Wolfenson H, Henis YI, Geiger B, Bershadsky AD. (2009). The heel and toe of the cell's foot: a multifaceted approach for understanding the structure and dynamics of focal adhesions. Cell Motil Cytoskeleton 66: 1017-1029.
33. Wu H, Parsons JT. (1993). Cortactin, an 80/85-kilodalton pp60src substrate, is a filamentous actin-binding protein enriched in the cell cortex. J Cell Biol 120: 1417-1426. (Pubitemid 23081688)
34. Wu H, Reynolds AB, Kanner SB, Vines RR, Parsons JT. (1991). Identification and characterization of a novel cytoskeleton-associated pp60src substrate. Mol Cell Biol 11: 5113-5124. (Pubitemid 21895272)
35. Xue C, Wyckoff J, Liang F, Sidani M, Violini S, Tsai KL et al. (2006). Epidermal growth factor receptor overexpression results in increased tumour cell motility in vivo coordinately with enhanced intravasation and metastasis. Cancer Res 66: 192-197. (Pubitemid 43166025)